Cancer Vaccines and Tumor Immunity

Regular price €182.22
Title
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
A01=Bryon D. Johnson
A01=James W. Hodge
A01=Rimas Orentas
academic
applied
area
Author_Bryon D. Johnson
Author_James W. Hodge
Author_Rimas Orentas
cancer
Category=MJCL
Category=PN
Category=PNB
clinical
emerging
enterprise
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_science
expert contributors
field
focused
ideas
infrastructure
large
progress
progressed
promise
research
science
smallscale
team
vaccine
vaccines
work

Product details

  • ISBN 9780470074749
  • Weight: 635g
  • Dimensions: 150 x 236mm
  • Publication Date: 11 Mar 2008
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: US
  • Product Form: Hardback
Secure checkout Fast Shipping Easy returns
Cancer Vaccines and Tumor Immunity offers a review of the basic scientific discoveries that have moved forward into clinical trials. Presented in the context of real-world human research and experimentation, these major scientific advances demonstrate how our understanding of immune activation, T-regulatory cells, and autoimmunity will impact cancer vaccine design. The authors also explain how vaccination in the context of bone marrow transplantation will open new avenues for clinical study in the future.
Rimas J. Orentas, PhD, is Associate Professor in the Department of Pediatrics, Section of Hematology-Oncology, and holds joint appointments in the Departments of Medicine and Microbiology and Molecular Genetics at the Medical College of Wisconsin in Milwaukee, Wisconsin.

James W. Hodge, PhD, is a Senior Scientist in the Laboratory of Tumor Immunology and Biology at the National Cancer Institute in Bethesda, Maryland.

Bryon D. Johnson, PhD, is Associate Professor in the Department ofPediatrics, Section of Hematology-Oncology at the Medical College of Wisconsin in Milwaukee, Wisconsin.

More from this author